Trial intelligence / Profile preview

Low vs High Dose Cyclophosphamide in Pediatric Lupus Nephritis

NCT01861561Phase 4Terminated

Sponsor
Mahidol University
Start
May 2013
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cyclophosphamide in lupus nephritis (LN), sponsored by Mahidol University. Started May 2013; status: terminated.

02

Drugs

cyclophosphamide
03

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on NCT01861561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01861561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call